Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Lam

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2019
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibodySuping Zhang, Han Zhang, Emanuela M Ghia, et al.
Nature Cancer|March 30, 2023
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumorsFiore Cattaruzza, Ayesha Nazeer, Milton To, et al.
Science Translational Medicine|May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivoPatrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Blood|September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyConrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
Science (New York, N.Y.)|October 7, 2016
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3Xiaobo Mao, Michael Tianhao Ou, Senthilkumar S Karuppagounder, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2019
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibodySuping Zhang, Han Zhang, Emanuela M Ghia, et al.
Nature Cancer|March 30, 2023
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumorsFiore Cattaruzza, Ayesha Nazeer, Milton To, et al.
Science Translational Medicine|May 1, 2015
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivoPatrick J Hanley, Jan J Melenhorst, Sarah Nikiforow, et al.
Blood|September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyConrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
Science (New York, N.Y.)|October 7, 2016
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3Xiaobo Mao, Michael Tianhao Ou, Senthilkumar S Karuppagounder, et al.
Pageof 3